Arunima Srivastava

Dosage-dependent copy number gains in E2f1 and E2f3 drive hepatocellular carcinoma

Lindsey N. Kent, Sooin Bae, Shih‐Yin Tsai et al. · Journal of Clinical Investigation · 2017 · 140 citations · Full text

Pathology, Transcriptome Profiling, Tumor Biology +17

E2f8 mediates tumor suppression in postnatal liver development

Lindsey N. Kent, Jessica Rakijas, Shusil K. Pandit et al. · Journal of Clinical Investigation · 2016 · 96 citations · Full text

Identification of an antimicrobial entity from the cyanobacterium Fischerella sp. isolated from bark of Azadirachta indica (Neem) tree

Ravi Kumar Asthana, Arunima Srivastava, Akhilesh P. Singh et al. · Journal of Applied Phycology · 2006 · 78 citations

Antimicrobial Entity, Cyanobacterium Fischerella Sp, Antimicrobial Susceptibility +9

Isolation and identification of a new antibacterial entity from the Antarctic cyanobacterium Nostoc CCC 537

Ravi Kumar Asthana, Deepali, Manoj Kumar Tripathi et al. · Journal of Applied Phycology · 2008 · 74 citations

Biology, Microbial Ecology, Antibacterial Agent +7

Redeployment of Myc and E2f1–3 drives Rb-deficient cell cycles

Huayang Liu, Xing Tang, Arunima Srivastava et al. · Nature Cell Biology · 2015 · 74 citations · Full text

Cell Regulation, Cell Division, Natural Sciences +7